tradingkey.logo
tradingkey.logo
Search

Artiva Biotherapeutics Inc

ARTV
Add to Watchlist
7.490USD
-0.230-2.98%
Close 09-24 16:00(ET)
363.94MMarket Cap
LossP/E TTM

ARTV Financials

See Artiva Biotherapeutics Inc's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.

Key Financial Ratios

Market Cap
363.94M
Dividend TTM
0.00
P/E TTM
-2.11
EPS TTM
-3.55
Revenue
0.00
Net Profit
-65.37M
ROE
-67.86%
ROA
-58.59%

Artiva Biotherapeutics Inc Earnings Date

Latest Release
Aug 6, 2026
EPS / Forecast
-0.63/-0.63
Revenue / Forecast
--/0.00

Financial Statement Highlights

Quarterly
Quarterly+Annual
Quarterly
Annual
FY2026Q2
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q1
Financial Indicators
EPS
27.23%-0.63
-14.20%-0.95
-28.08%-0.85
4.89%-0.88
-13.76%-0.87
-39.12%-0.83
---0.66
---0.92
-58.12%-0.77
16.47%-0.60
----
----
---0.48
---0.72
----
----
Revenue
----
----
--0.00
--0.00
--0.00
-100.00%0.00
--0.00
--0.00
-100.00%0.00
-74.62%251.00K
----
----
--3.50M
-26.63%989.00K
----
--1.35M
Net Profit
-17.65%-25.00M
-15.78%-23.52M
-29.06%-20.77M
-23.21%-21.53M
-19.12%-21.25M
-45.46%-20.31M
---16.09M
---17.47M
-58.13%-17.84M
16.47%-13.96M
----
----
---11.28M
-37.88%-16.72M
----
---12.12M
Net Margin
----
----
----
----
----
----
----
----
----
-229.11%-5562.95%
----
----
---322.68%
---1690.29%
----
----
Gross Margin
----
----
----
----
----
----
----
----
----
0.00%100.00%
----
----
--100.00%
--100.00%
----
----
Debt to assets ratio
-100.00%0.00%
-85.51%0.01%
-57.58%0.03%
-41.41%0.05%
-78.60%0.06%
--0.07%
--0.08%
--0.09%
--0.29%
----
----
----
----
----
----
----
Revenue
----
----
--0.00
--0.00
--0.00
-100.00%0.00
--0.00
--0.00
-100.00%0.00
-74.62%251.00K
----
----
--3.50M
-26.63%989.00K
----
--1.35M
Operating profit
-17.89%-26.89M
-10.19%-24.43M
-20.06%-21.93M
-24.88%-22.90M
-40.89%-22.81M
-52.99%-22.17M
---18.27M
---18.34M
-36.92%-16.19M
18.07%-14.49M
----
----
---11.82M
-45.89%-17.69M
----
---12.12M
Net Profit
-17.65%-25.00M
-15.78%-23.52M
-29.06%-20.77M
-23.21%-21.53M
-19.12%-21.25M
-45.46%-20.31M
---16.09M
---17.47M
-58.13%-17.84M
16.47%-13.96M
----
----
---11.28M
-37.88%-16.72M
----
---12.12M
Current assets
136.32%352.28M
-47.80%88.74M
-40.27%112.67M
-13.97%129.52M
199.64%149.07M
158.03%170.00M
--188.63M
--150.56M
--49.75M
--65.89M
----
----
----
----
--104.67M
--153.22M
Total current liabilities
35.41%14.58M
-10.85%10.88M
6.81%13.09M
-16.35%11.12M
-0.54%10.77M
17.71%12.20M
--12.25M
--13.29M
--10.83M
--10.37M
----
----
----
----
--25.63M
--22.62M
Total assets
117.62%368.63M
-44.60%105.95M
-37.52%130.94M
-34.01%148.86M
123.14%169.39M
112.13%191.26M
--209.58M
--225.60M
--75.91M
--90.16M
----
----
----
----
--133.05M
--161.83M
Total liabilities
3.84%21.13M
-19.45%18.11M
-8.59%20.97M
-20.17%19.64M
-59.78%20.35M
-53.57%22.48M
--22.94M
--24.60M
--50.60M
--48.42M
----
----
----
----
--57.34M
--44.83M
Total equity
133.16%347.50M
-47.95%87.85M
-41.08%109.97M
-35.71%129.22M
488.72%149.04M
304.37%168.78M
--186.64M
--201.00M
--25.32M
--41.74M
----
----
----
----
--75.72M
--117.00M
Net operating income
11.43%-20.36M
-5.59%-20.95M
-0.52%-14.73M
-65.37%-19.20M
-67.94%-22.98M
-31.52%-19.84M
---14.65M
---11.61M
-16.33%-13.69M
-5.92%-15.09M
----
----
---11.76M
-47.38%-14.24M
----
---9.66M
Net investment
-16.75%17.59M
53.61%15.32M
1760.46%16.04M
112.46%16.28M
1465.75%21.12M
1.93%9.97M
---966.00K
---130.63M
106.44%1.35M
625.35%9.78M
----
----
---20.95M
-209.30%-1.86M
----
---602.00K
Net financing
393529.17%283.27M
-146.86%-112.00K
-303.33%-121.00K
-100.02%-37.00K
95.54%-72.00K
--239.00K
---30.00K
--163.87M
-16260.00%-1.62M
----
----
----
--10.00K
96.07%-12.00K
----
---305.00K

Revenue

By Business

Period:
No Data

By Region

Period:
No Data

FAQs

What are the current assets of Artiva Biotherapeutics Inc?

According to Artiva Biotherapeutics Inc's FY2025 earnings report, its current assets were 112.67M, with a year-on-year change of -40.27.

What are the total assets of Artiva Biotherapeutics Inc?

According to Artiva Biotherapeutics Inc's FY2025 earnings report, its total assets of Artiva Biotherapeutics Inc were 130.94M, with a year-on-year change of -37.52.

What are the total liabilities of Artiva Biotherapeutics Inc?

According to Artiva Biotherapeutics Inc's FY2025 earnings report, its total liabilities of Artiva Biotherapeutics Inc were 20.97M, with a year-on-year change of -8.59.

What is the total equity of Artiva Biotherapeutics Inc?

According to Artiva Biotherapeutics Inc's FY2025 earnings report, its total equity of Artiva Biotherapeutics Inc was 109.97M, with a year-on-year change of -41.08.

What is the net operating income of Artiva Biotherapeutics Inc?

According to Artiva Biotherapeutics Inc's FY2025 earnings report, its net operating income of Artiva Biotherapeutics Inc was -89.81M, with a year-on-year change of -33.48.

What is the net investment of Artiva Biotherapeutics Inc?

According to Artiva Biotherapeutics Inc's FY2025 earnings report, its net investment of Artiva Biotherapeutics Inc was 63.41M, with a year-on-year change of 152.64.

What is the net financing of Artiva Biotherapeutics Inc?

According to Artiva Biotherapeutics Inc's FY2025 earnings report, its net financing of Artiva Biotherapeutics Inc was 9.00K, with a year-on-year change of -99.99.

What is the Earnings Per Share (EPS) of Artiva Biotherapeutics Inc?

According to Artiva Biotherapeutics Inc's FY2025 earnings report, its Earnings Per Share (EPS) was -3.43, with a year-on-year change of 40.91.

What is the net income of Artiva Biotherapeutics Inc?

According to Artiva Biotherapeutics Inc's FY2025 earnings report, its net income was -83.86M, with a year-on-year change of -28.29.

What is the debt-to-asset ratio of Artiva Biotherapeutics Inc?

According to Artiva Biotherapeutics Inc's FY2025 earnings report, its debt-to-asset ratio was 0.03, with a year-on-year change of -57.58.

What is the Return on Equity (ROE) of Artiva Biotherapeutics Inc?

According to Artiva Biotherapeutics Inc's FY2025 earnings report, its Return on Equity (ROE) was -56.55, with a year-on-year change of 89.35.

What is the Return on Assets (ROA) of Artiva Biotherapeutics Inc?

According to Artiva Biotherapeutics Inc's FY2025 earnings report, its Return on Assets (ROA) was -49.26, with a year-on-year change of -18.56.

What is the operating profit of Artiva Biotherapeutics Inc?

According to Artiva Biotherapeutics Inc's FY2025 earnings report, its operating profit was -89.81M, with a year-on-year change of -33.48.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.